Clinical Trial Update: Lenalidomide Combined With R-CHOP(R2-CHOP) in Newly Diagnosed Double-expressor Diffuse Large B-Cell Lymphoma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lenalidomide combined with R-CHOP (R2-CHOP) for newly diagnosed double-expressor diffuse large B-cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Lenalidomide (lenalidomide)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Fudan University | Conditions: Double Expressor Lymphoma | Phase 2 | Status: COMPLETED